entity

LXRβ

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LXRβ: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

8Connections
7Hypotheses
1Analyses
6Outgoing
2Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (6)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:LXRΒdata_indataset_row0.00
h-3f4cb83e0ctargeted_byhypothesis1.00
BDNFregulatesgene0.80
ABCA1regulatesprotein0.70
ABCG1regulatesprotein0.70

Incoming (2)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:LXRΒdata_indataset_row0.00
h-3f4cb83e0ctargetshypothesis1.00

Targeting Hypotheses (7)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Selective LXRβ agonists restore ABCA1/ABCG1 expression and A 0.763 neuroscience APOE4-driven lipid metabolism dysregulat
LXRβ-Selective Agonism as a Precision Therapeutic for APOE4- 0.721 neurodegeneration What specific molecular mechanisms link
LXRβ-Selective Agonism to Simultaneously Enhance APOE Lipida 0.668 lipidomics Lipid metabolism dysregulation in Alzhei
OPC Maturation Block via PDGFRA/LXRβ 0.620 neurodegeneration Methodology challenge: dataset 'Allen Br
LXRβ-Selective Agonism Enhances CYP2J2-Mediated DHA Epoxide 0.380 lipidomics Lipid metabolism dysregulation in Alzhei
ABCA1 Upregulation via LXRβ Agonism to Enhance Cholesterol E 0.380 lipidomics Lipid metabolism dysregulation in Alzhei
CYP2J2-Generated DHA Epoxides Enhance LXRβ-Mediated APOE Lip 0.380 lipidomics Lipid metabolism dysregulation in Alzhei

Mentioning Analyses (1)

Scientific analyses that reference this entity

APOE4-driven lipid metabolism dysregulation in astrocytes and its role in AD

neuroscience | 2026-04-04 | 7 hypotheses Top: 0.763

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

APOE4 is the strongest genetic risk factor for late-onset AD. How APOE4 specific

closed · Rounds: 4 · Score: 0.78 · 2026-04-22

Related Research

Hypotheses and analyses mentioning LXRβ in their description or question text

ABCA1 Upregulation via LXRβ Agonism to Enhance Cholesterol Efflux and Prevent Ne

Score: 0.380 · lipidomics · 2026-04-26

This hypothesis proposes that selective LXRβ agonism primarily functions through transcriptional upregulation of ABCA1 (

CYP2J2-Generated DHA Epoxides Enhance LXRβ-Mediated APOE Lipidation for Synergis

Score: 0.380 · lipidomics · 2026-04-26

This hypothesis proposes that CYP2J2-generated DHA epoxides act as endogenous LXRβ agonists, creating a synergistic mech